Alam, S., Doherty, E., Ortega-Prieto, P., Arizanova, J., & Fets, L. (2023). Membrane transporters in cell physiology, cancer metabolism and drug response. Disease Models & Mechanisms, 16(11). https://doi.org/10.1242/dmm.050404

Fets, L., Bevan, N., Nunes, P.M., Campos S., Silva Dos Santos M., Sherriff E., MacRae J. I, House D., Anastasiou D. (2022). MOG analogues to explore the MCT2 pharmacophore, α-ketoglutarate biology and cellular effects of N-oxalylglycine. Commun Biol 5, 877. https://doi.org/10.1038/s42003-022-03805-y

Newton H, Wang Y, Camplese L, Mokochinski JB, Kramer HB, Brown AEX, Fets L, Hirabayashi S. (2020). Systemic muscle wasting and coordinated tumour response drive tumourigenesis. Nature Communications 11, 4653.

Fets L, Driscoll PC, Grimm F, Jain A, Nunes PM, Gounis M, Doglioni G, Papageorgiou G, Ragan TJ, Campos S, dos Santos MS, MacRae JI, O’Reilly N, Wright AJ, Benes CH, Courtney KD, House D, Anastasiou D. (2018). MCT2 mediates concentration-dependent inhibition of glutamine metabolism by MOG. Nat Chem Biol 14, 1032–1042.

Macpherson JA, Theisen A, Masino L, Fets L, Driscoll PC, Encheva V, Snijders AP, Martin SR, Kleinjung J, Barran PE, Fraternali F, Anastasiou D. (2019). Functional cross-talk between allosteric effects of activating and inhibiting ligands underlies PKM2 regulation. eLife 2019;8:e45068.

Clark J, Kay RR, Kielkowska A, Niewczas I, Fets L, Oxley D, et al. Dictyostelium uses ether-linked inositol phospholipids for intracellular signalling. (2014). EMBO J 33(19), 2188–2200.

Fets L, Nichols JME, Kay RR. A PIP5 kinase essential for efficient chemotactic signaling. (2014). Curr Biol 24(4), 415–21.